Symptoms and diagnosis
Usage examples
Medicinal plants
Frequent searches
Medical search
Health topics
Healthy weight
Medical dictionary
Health sites
Questions and answers

Training the body to fight melanoma
One person dies of melanoma every hour and one in fifty men and women will be diagnosed with melanoma at some point in their lifetime. Now a new experimental therapy is training the body's immune system to fight the disease. Todd Greenlee has been in ...
KLAS-TV - Mon, 01 Sep 2014 10:37

Cancer drug fighting melanoma - Sun, 31 Aug 2014 23:00

New techniques helping curb advanced melanoma - Mon, 01 Sep 2014 02:00

Tanning on sunbeds and package holidays to blame for 41% increase in skin ... - Mon, 01 Sep 2014 15:52

Hospitals see rapid rise in skin cancer
BBC News - Mon, 01 Sep 2014 16:03

Experimental therapy trains patients' immune systems to fight melanoma
On the heels of a push from the U.S. surgeon general to act as the number of skin cancer cases rapidly increases, researchers are testing an experimental therapy that trains the body's immune system to fight melanoma. Melanoma, the most dangerous form ...
Fox News - Tue, 26 Aug 2014 07:09

Fighting melanoma with immune system: new therapy
KABC-TV - Mon, 25 Aug 2014 20:51

High-Risk Melanomas Often on Head or Neck
Rapid cell growth -- called "high mitotic rate" -- is associated with poorer prognosis in patients with melanoma. For this new study, the Australian research team examined the physical characteristics of melanomas and their rate of cell division to ...
WebMD - Wed, 20 Aug 2014 13:03

Patient, tumor characteristics for high-mitotic rate melanoma
EurekAlert (press release) - Wed, 20 Aug 2014 13:15

High-Risk Melanomas Often on Head or Neck, Study Finds - Wed, 20 Aug 2014 13:03

Clinicopathology of High-Mitotic Rate Melanoma Described
HCPLive - Thu, 21 Aug 2014 09:41

Merck's Melanoma Drug To Get FDA Approval Earlier Than Expected
Merck & Co., Inc. (MRK) might obtain the US Food and Drug Administration's approval for its high-profile experimental melanoma drug earlier than expected. The FDA was supposed to give a verdict on October 28, but Reuters reported that three sources who ...
Bidness ETC - Tue, 26 Aug 2014 06:03

Melanoma drug soon to be approved by FDA
iStreet Research - Mon, 25 Aug 2014 14:56

New Cancer Drug 'Big Deal' for Melanoma Patients
Newsmax Health - Mon, 25 Aug 2014 10:03

Exclusive: US approval of Merck cancer immunotherapy expected soon
Reuters - Mon, 25 Aug 2014 04:06

Merck'S Cancer (Melanoma) Immunotherapy Drug may Get FDA approval
Capital OTC - Mon, 25 Aug 2014 10:27

Skin cancer rates rising fastest in older men
Melanoma is more common in men on the back, where it is difficult to spot early changes in a mole. Experts believe the rapidly rising rate in older people is partly because it is difficult to distinguish skin cancer from other harmless ailments, such ...
Daily Mail - Fri, 29 Aug 2014 16:29

Sunbed use increases risk of cancer more common than melanoma - Sat, 30 Aug 2014 16:03

Melanoma skin cancer rates rising fastest in older men
Delhi Daily News - Sat, 30 Aug 2014 02:33

Skin cancer cases double in 30 years but survival rates also rise
BBC News - Sun, 31 Aug 2014 23:56

Sunbeds can cause cancer – even if you don't burn - Sun, 31 Aug 2014 16:03

Less sunscreen and popularity of indoor tanning beds up melanoma risk among ...
There is an increase in the risk of melanoma among teens who do not use sunscreen when outside or partake in the popular tanning bed industry, a new report warns. The report, published in Preventing Chronic Disease from the United States Centers for ...
Tech Times - Sun, 24 Aug 2014 06:18

Fewer US teenagers using sunscreen, study finds
Fox News - Fri, 22 Aug 2014 06:56

Unhealthy Tans: US Kids Less Likely to Use Sunscreen - Thu, 21 Aug 2014 16:57

Study: Fewer teenagers using sunscreen
WLS-TV - Thu, 21 Aug 2014 12:52

New Melanomas Likely to Recur at Same Rate
For the first 2 years after initial diagnosis, invasive melanoma had a greater risk of invasive recurrence, as compared with an initial diagnosis of in situ disease. Thereafter, the risk of invasive recurrence remains the same, regardless of the ...
MedPage Today - Sat, 09 Aug 2014 12:45

Amelanotic melanoma linked with advanced stage at diagnosis
Previous studies have indicated that poorer survival rate of amelanotic melanoma as compared to pigmented melanoma is due to advanced stage at diagnosis; however these studies had several limitations including limited number of cases and lack of ...
2 Minute Medicine - Sun, 31 Aug 2014 14:18

1  2  3  4  5  6  7  8    ->

Last update: September 2014

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014